TrialHuman vaccines & immunotherapeutics2026

Immunogenicity and safety of a 2 + 1 schedule of the DTaP-IPV-HB-Hib hexavalent combination vaccine in preterm infants in Spain.

Ignacio Salamanca de la Cueva et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.